Tradestie Institutional Equity Comparison Engine
AAPG vs BDCI โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
BDCI Overall Edge
BDCI Captures Institutional Edge (2โ1 Pillars ยท 6โ4 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to BDCI (BDCI) driven by superior Growth & Margin, Momentum & Technical while AAPG counters with relative strength in Valuation. Fundamentally, AAPG trades at 8.4x Forward P/E with -219.5% operating margin (+29.3% YoY revenue) versus BDCI at N/M Forward P/E and 0.0% operating margin (+0.0% YoY). In options structure, AAPG sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against BDCI sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).
Valuation Winner
AAPG
AAPG 8.4x vs BDCI N/M Fwd P/E
Growth & Margin Winner
BDCI
Op Margin -219.5% vs 0.0% ยท YoY +29.3% vs +0.0%
Momentum & Technical Winner
BDCI
1Y -64.0% vs +0.3% ยท 52W Pos 0% vs 73%
Options & Structure Winner
Tie
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (N/A IV)
AAPG
NASDAQ
Ascentage Pharma Group International American Depository Shares
Pharmaceutical Preparations
$11.97
-3.78% 1D
Market Cap
$1.2B
1M Return
-19.77%
1Y Return
-64.0%
Forward P/E
8.4x
Unified AI Score
37.1 / 100
SELL
Tech 25.0
Fund 42.0
Flow 50.0
Mom 55.0
BDCI
US Equity
BDCI
Institutional Equity
$10.18
+0.0% 1D
Market Cap
$353.7M
1M Return
+0.3%
1Y Return
+0.3%
Forward P/E
N/M
Unified AI Score
53.8 / 100
HOLD
Tech 43.0
Fund 50.0
Flow 50.0
Mom 46.2
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
AAPG -64.0%
BDCI +0.3%
Spread: +64.39 pp (BDCI Lead)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
AAPG TTM Op. Margin: -219.5%
BDCI TTM Op. Margin: 0.0%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on AAPG vs BDCI. Trailing 12-month operating profitability (AAPG -219.5% vs BDCI 0.0%) and valuation multiples (AAPG 8.4x vs BDCI N/M Forward P/E) are benchmarked directly in Pillar 4 below.
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | AAPG | BDCI | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $1.2B | $353.7M | Larger Scale | AAPG |
| Trailing P/E Ratio Valuation | 8.4x | 46.3x | Lower Multiple | AAPG |
| Forward P/E Ratio Valuation | 8.4x | N/M | Lower Multiple | AAPG |
| Revenue Growth (YoY) Growth | +29.3% | +0.0% | Higher Growth | AAPG |
| Operating Margin (TTM) Profitability | -219.5% | 0.0% | Higher Margin | BDCI |
| Net Profit Margin Profitability | -228.5% | 0.0% | Higher Margin | BDCI |
| Return on Equity (ROE) Capital Efficiency | -236.6% | 6.0% | Higher ROE | BDCI |
| 52-Week Range Position Momentum | 0% ($12โ$34) | 73% ($10โ$10) | Stronger Trend | BDCI |
| Beta / 30D Volatility Risk Regime | 1.36ฮฒ ยท 64% Vol | 0.00ฮฒ ยท 1% Vol | Lower Realized Risk | BDCI |
| Unified Institutional Score Composite Signal | 37.1 / 100 (SELL) | 53.8 / 100 (HOLD) | Higher Composite | BDCI |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full AAPG vs BDCI Buy Guide
AAPG
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
BDCI
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither AAPG nor BDCI registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.